Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Risk%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22Risk%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22Risk%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (9.458)
1
A clinical study to compare brincidofovir with current care for adenovirus infection in children after a bone marrow transplant : An Open-label, Randomized, Multi-center, Parallel Group, Two-arm Study to Assess the Safety, Overall Tolerability, and Antiviral Activity of Brincidofovir versus Standard of Care for Treatment of Adenovirus Infections in High-risk Pediatric Allogeneic Hematopoietic Cell Transplant Recipients - AdAPT: Adenovirus after Allogeneic Pediatric Transplantation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
A phase II clinical trial for patients with node-negative stage I-II intermediate or high risk endometrial cancer where the patients will be divided into 2 groups; chemotherapy after surgery versus observation only. : A phase II Trial of postoperative chemotherapy or no further treatment for patients with node-negative stage I-II intermediate or high risk endometrial cancer. - ENGOT-EN2-DGCG
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Long term continuous infusion ch14.18/CHO plus s.c. aldesleukin (IL-2) randomised : A PHASE I/II DOSE SCHEDULE FINDING STUDYFOR CH14.18/CHO CONTINUOUS INFUSION COMBINED WITH SUBCUTANEOUS ALDESLEUKIN (IL-2)IN PATIENTS WITH PRIMARY REFRACTORY OR RELAPSING NEUROBLASTOMA - Long term continuous infusion ch14.18/CHO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Home Treatment of Patients with Low-Risk Pulmonary Embolism with Rivaroxaban : Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban: Prospective Management Trial (HoT-PE) - HoT-PE
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A randomized Phase III study to compare arsenic trioxide (ATO) combined to ATRA and idarubicin versus standard ATRA and anthracyclines-based chemotherapy (AIDA regimen) for patients with newly diagnosed, high-risk acute promyelocytic leukemia : A randomized Phase III study to compare arsenic trioxide (ATO) combined to ATRA and idarubicin versus standard ATRA and anthracyclines-based chemotherapy (AIDA regimen) for patients with newly diagnosed, high-risk acute promyelocytic leukemia - APOLLO
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A study to assess if two different doses of Nefecon taken as capsules are safe and effective in patients with primary IgA nephropathy at risk of developing end-stage renal disease : A Multicentre, Interventional Treatment, Randomised, Double-Blind, Single Group Assignment, Placebo Controlled Study to Evaluate the Efficacy and Safety of Two Different Doses of Nefecon® in Primary IgA Nephropathy Patients at Risk of Developing End-Stage Renal Disease - The NEFIGAN Trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A Clinical Trial for Newly Diagnosed High Risk Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer : A Randomized, Multicenter, Double-blind, Placebo-controlled Phase 3 Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in Patients With High-risk, Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer(CheckMate 7FL: CHECKpoint pathway and nivoluMAb clinical Trial Evaluation 7FL) - Nivo/Placebo with Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy in ER+/HER2-Breast Cancer
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A Phase 2 Clinical Trial in Patients with Acute Myeloid Leukemia (AML). : A Phase 2, Randomized, Biomarker-driven, Clinical Study in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with an Exploratory Arm in Patients with Newly Diagnosed High-Risk AML and ExploratoryArms with Varying Levels of MCL-1 Dependence
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
An international study comparing two treatment strategies for metastatic neuroblastoma patients with poor response to induction chemotherapy : An international multicenter phase II randomised trial evaluating and comparing two intensification treatment strategies for metastatic neuroblastoma patients with a poor response to induction chemotherapy - VERITAS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
Study of Antithrombotic Treatment after Intracerebral Haemorrhage (STATICH) : Study of Antithrombotic Treatment after Intracerebral Haemorrhage (STATICH)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[946]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
9.458
Aufsätze
9.458
E-Artikel
9.458
E-Ressourcen
Zeitschriftentitel
8.202
WHO International Clinical Trials Registry Plat...
1.256
ClinicalTrials.gov
Thema
9.458
610
8.270
Study Type: Interventional
3.528
Recruitment Status: Not yet recruiting
2.247
Phase: Phase 3
2.094
Recruitment Status: Completed
1.910
Recruitment Status: Authorised-recruitment may ...
1.152
Phase: Phase 2
1.056
Recruitment Status: Recruiting
984
Study Type: Observational
426
Phase: Phase 4
286
Recruitment Status: Complete: follow-up complete
260
Phase: Phase 1
122
Recruitment Status: Unknown status
109
Cardiovascular Diseases
96
Recruitment Status: Active, not recruiting
96
Study Type: Observational non invasive
58
Phase: Phase 1/Phase 2
58
Recruitment Status: Terminated
56
Recruitment Status: Complete: follow-up continuing
54
Phase: Phase 0
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
5.443
2020-
3.982
2010-2019
33
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
9.294
Englisch
86
Unbestimmt
32
Niederländisch
20
Spanisch
6
Französisch
6
Deutsch
6
Italienisch
2
Dänisch
2
Finnisch
2
Isländisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...